Check out a new white paper describing the joint efforts of Hypha and Galchimia, who together successfully synthesised metabolites of… read more →
Hypha were honoured to be asked to contribute a chapter on “Metabolite Generation and Metabolite Characterization by NMR” in the… read more →
This is an exciting opportunity for an intern to spend time on a research project to further exemplify the use… read more →
Hypha are excited to announce they have relocated from Slough to Milton Park in Oxfordshire, one of the largest science… read more →
Metabolites derived from any human flavin-containing monooxygenase (FMO) subtype can now be produced as a service offering at Hypha. Recombinant… read more →
Great to see Hypha recognised for producing a glucuronide metabolite of praliciguat (M3) in the paper just out in the… read more →
We illustrate application of our one-stop metabolite shop in meeting metabolite requirements for various client projects using different techniques in… read more →
Hypha remain fully operational and are monitoring the COVID-19 situation closely. We have implemented a number of measures in response… read more →
Some metabolites are not easy to access. Even if sufficient material can be isolated from biological matrices for definitive metID,… read more →
As a leading specialist CRO for drug metabolite provision, Hypha has formed a partnership with Cypex Limited, experts in the… read more →